{"id":25104,"date":"2013-02-28T13:49:00","date_gmt":"2013-02-28T12:49:00","guid":{"rendered":"https:\/\/www.embl.org\/news\/?p=25104"},"modified":"2024-03-26T00:34:14","modified_gmt":"2024-03-25T23:34:14","slug":"zeroing-in-on-heart-disease","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/","title":{"rendered":"Zeroing in on heart disease"},"content":{"rendered":"\n<div\n  class=\"vf-box vf-box--inlay\">\n\n  <h3 class=\"vf-box__heading\">In a nutshell:<\/h3>\n  <p class=\"vf-box__text\">&#8211; Genome-wide association studies (GWAS) enable scientists to trace the origin of human diseases to distinct regions in the genome, but their resolution is limited<br \/>&#8211; RNA interference is a powerful technology to test, in parallel, the function of many genes<br \/>&#8211; The combination of these two approaches pinpoints what genes are the most important for the control of cholesterol levels, and thus likely to confer a risk for cardiovascular disease<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"vf-figure  | vf-figure--align vf-figure--align-inline-start   size-medium\"><a href=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg.jpg\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"300\" class=\"vf-figure__image\" src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-300x300.jpg\" alt=\"\" class=\"wp-image-25106\" srcset=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-300x300.jpg 300w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-150x150.jpg 150w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-768x768.jpg 768w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg.jpg 800w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><figcaption class=\"vf-figure__caption\">Cells stained for observation by fluorescence microscopy to discover cholesterol-regulatory genes\n(top left: cholesterol (orange) uptake by cells; top right: free cholesterol (blue) in cells; bottom left: localisation of a protein (green) involved in cholesterol regulation; bottom right: automated image-analysis showing the cell outer membrane (grey) and the cholesterol (white)).\nCredit:EMBL\/Peter Blattmann and University of Heidelberg\/Christian Schuberth<\/figcaption><\/figure><\/div>\n\n\n\n<p>Studies screening the genome of hundreds of thousands of individuals (known as Genome-wide association studies or GWAS) have linked more than 100 regions in the genome to the risk of developing cardiovascular disease. Researchers from\u00a0the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, through the joint\u00a0<a href=\"https:\/\/www.embl.org\/partnerships\/local\/molecular-medicine-partnership-unit\/\">Molecular Medicine Partnership Unit<\/a>\u00a0(MMPU),\u00a0are taking these results one step further by pinpointing the exact genes that could have a role in the onset of the disease. Their findings are published today in the\u00a0<em>Public Library of Science (PLoS) Genetics<\/em>.<\/p>\n\n\n\n<p>The scientists used a technology called \u201cRNA interference\u201d that can selectively decrease the level of expression of targeted genes. By observing what changes, if any, this decrease causes in cells, researchers can identify the function of the genes and, on a larger scale, objectively test the function of many genes in parallel.<\/p>\n\n\n\n<p>Cholesterol levels in the blood are one of the main risk factors for cardiovascular disease. They are controlled by the amount of cholesterol that cells can take in &#8211; thus removing it from the blood &#8211; and metabolise. The researchers used RNA interference to test the function of each of the genes within 56 regions previously identified by GWAS as being linked with cardiovascular disease. They selectively decreased their action and measured what, if any, changes this induced in cholesterol metabolism. From this they could deduce which of the genes are most likely to be involved in the onset of the disease.<\/p>\n\n\n\n<p>\u201cThis is the first wide\u2013scale RNA interference study that follows up on GWAS. It has proven its potential by narrowing down a large list of candidate genes to the few with an important function that we can now focus on in future in-depth studies,\u201d explains\u00a0<a href=\"http:\/\/embl.org\/groups\/pepperkok\/\">Rainer Pepperkok<\/a>\u00a0at EMBL, who co-led the study with Heiko Runz at the University of Heidelberg.\u00a0<\/p>\n\n\n\n<p>\u201cIn principle, our approach&nbsp;can be applied to any disease that has an observable effect on cells\u201d, adds Heiko Runz. \u201cThe genes identified here may further our understanding of the mechanisms leading to cardiovascular disease and allow us to improve its prediction and diagnosis\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Studies screening the genome of hundreds of thousands of individuals (known as Genome-wide association studies or GWAS) have linked more than 100 regions in the genome to the risk of developing cardiovascular disease. Researchers from\u00a0the European Molecular Biology Laboratory (EMBL) and the&hellip;<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2,17591],"tags":[1786,1794,70],"embl_taxonomy":[],"class_list":["post-25104","post","type-post","status-publish","format-standard","hentry","category-science","category-science-technology","tag-cholesterol","tag-disease","tag-rna"],"acf":{"show_featured_image":false,"vf_locked":false,"featured":false,"article_intro":"<p>Innovative strategy pinpoints genes underlying cardiovascular disease risk<\/p>\n","article_sources":[{"source_description":"<p>RNAi-based functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function &#8211; Peter Blattmann, Christian Schuberth, Rainer Pepperkok, and Heiko Runz \u2013 Published in the <em>Public Library of Science (PLoS) Genetics<\/em> on the 28 February 2013 \u2013 DOI: 10.1371\/journal.pgen.1003338<\/p>\n","source_link_url":"http:\/\/www.plosgenetics.org\/doi\/pgen.1003338"}],"related_links":[{"link_description":"More information on the Pepperkok team ","link_url":"https:\/\/www.embl.org\/groups\/pepperkok\/"},{"link_description":"More information on the Advanced Light Microscopy Facility","link_url":"https:\/\/www.embl.org\/groups\/advanced-light-microscopy-core-facility\/"}],"in_this_article":false,"color":"#007B53","youtube_url":"","mp4_url":"","video_caption":"","press_contact":"EMBL Generic","field_target_display":"embl","source_article":false},"embl_taxonomy_terms":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Zeroing in on heart disease | EMBL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zeroing in on heart disease | EMBL\" \/>\n<meta property=\"og:description\" content=\"Studies screening the genome of hundreds of thousands of individuals (known as Genome-wide association studies or GWAS) have linked more than 100 regions in the genome to the risk of developing cardiovascular disease. Researchers from\u00a0the European Molecular Biology Laboratory (EMBL) and the&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-02-28T12:49:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-25T23:34:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-300x300.jpg\" \/>\n<meta name=\"author\" content=\"Guest author(s)\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guest author(s)\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/\"},\"author\":{\"name\":\"Guest author(s)\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\"},\"headline\":\"Zeroing in on heart disease\",\"datePublished\":\"2013-02-28T12:49:00+00:00\",\"dateModified\":\"2024-03-25T23:34:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/\"},\"wordCount\":414,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-300x300.jpg\",\"keywords\":[\"cholesterol\",\"disease\",\"rna\"],\"articleSection\":[\"Science\",\"Science &amp; Technology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/\",\"url\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/\",\"name\":\"Zeroing in on heart disease | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-300x300.jpg\",\"datePublished\":\"2013-02-28T12:49:00+00:00\",\"dateModified\":\"2024-03-25T23:34:14+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg.jpg\",\"width\":800,\"height\":800,\"caption\":\"Cells stained for observation by fluorescence microscopy to discover cholesterol-regulatory genes (top left: cholesterol (orange) uptake by cells; top right: free cholesterol (blue) in cells; bottom left: localisation of a protein (green) involved in cholesterol regulation; bottom right: automated image-analysis showing the cell outer membrane (grey) and the cholesterol (white)). Credit:EMBL\/Peter Blattmann and University of Heidelberg\/Christian Schuberth\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\",\"name\":\"Guest author(s)\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"caption\":\"Guest author(s)\"},\"description\":\"Guest author(s)\",\"url\":\"https:\/\/www.embl.org\/news\/author\/guest-author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zeroing in on heart disease | EMBL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/","og_locale":"en_US","og_type":"article","og_title":"Zeroing in on heart disease | EMBL","og_description":"Studies screening the genome of hundreds of thousands of individuals (known as Genome-wide association studies or GWAS) have linked more than 100 regions in the genome to the risk of developing cardiovascular disease. Researchers from\u00a0the European Molecular Biology Laboratory (EMBL) and the&hellip;","og_url":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2013-02-28T12:49:00+00:00","article_modified_time":"2024-03-25T23:34:14+00:00","og_image":[{"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-300x300.jpg","type":"","width":"","height":""}],"author":"Guest author(s)","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Guest author(s)","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/"},"author":{"name":"Guest author(s)","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b"},"headline":"Zeroing in on heart disease","datePublished":"2013-02-28T12:49:00+00:00","dateModified":"2024-03-25T23:34:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/"},"wordCount":414,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-300x300.jpg","keywords":["cholesterol","disease","rna"],"articleSection":["Science","Science &amp; Technology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/","url":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/","name":"Zeroing in on heart disease | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg-300x300.jpg","datePublished":"2013-02-28T12:49:00+00:00","dateModified":"2024-03-25T23:34:14+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/science\/zeroing-in-on-heart-disease\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2020\/05\/130228_Heidelberg.jpg","width":800,"height":800,"caption":"Cells stained for observation by fluorescence microscopy to discover cholesterol-regulatory genes (top left: cholesterol (orange) uptake by cells; top right: free cholesterol (blue) in cells; bottom left: localisation of a protein (green) involved in cholesterol regulation; bottom right: automated image-analysis showing the cell outer membrane (grey) and the cholesterol (white)). Credit:EMBL\/Peter Blattmann and University of Heidelberg\/Christian Schuberth"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b","name":"Guest author(s)","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","caption":"Guest author(s)"},"description":"Guest author(s)","url":"https:\/\/www.embl.org\/news\/author\/guest-author\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":false,"featured_image_src":"https:\/\/www.embl.org\/news\/wp-includes\/images\/media\/default.svg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/25104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=25104"}],"version-history":[{"count":5,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/25104\/revisions"}],"predecessor-version":[{"id":49798,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/25104\/revisions\/49798"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=25104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=25104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=25104"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=25104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}